Evidence map›Paper›PMID 29046457›Full record

ArticleJournal of virology2018

HIV-1 Infection of Primary CD4

George R Young, Sandra N Terry, Lara Manganaro, Alvaro Cuesta-Dominguez, Gintaras Deikus, Dabeiba Bernal-Rubio, Laura Campisi, Ana Fernandez-Sesma, Robert Sebra, Viviana Simon and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. The Role of Human Endogenous Retrovirus (HERV)-K119International journal of molecular sciences · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Human Endogenous Retroviruses in Diseases.Sub-cellular biochemistry · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

George R Young *The Francis Crick Institute, London, United Kingdom.
Sandra N Terry *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lara ManganaroDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Alvaro Cuesta-DominguezDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Gintaras DeikusDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Dabeiba Bernal-RubioDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Laura CampisiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ana Fernandez-SesmaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Robert SebraDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Viviana SimonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lubbertus C F MulderDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA lubbertus.mulder@mssm.edu.
Icahn School of Medicine at Mount Sinai · USThe Francis Crick Institute · GB

Funding

Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MERAD, MIRIAM · 2015 to 2021
$46.6M
HIV Evolution Driven by Intracellular DefensesR01AI064001 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIMON, VIVIANA A · 2005 to 2015
$3.8M
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUSR01AI073450 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FERNANDEZ-SESMA, ANA · 2008 to 2017
$3.3M
HIV restriction by APOBEC3AR01AI120998 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIMON, VIVIANA A · 2016 to 2020
$2.4M
Impact of HERV-K expression on HIV-1 life cycleR01GM113886 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, LUBBERTUS C · 2014 to 2018
$1.8M
HUMAN TONSIL EXPLANTS AS A NOVEL MODEL FOR STUDYING DENGUE VIRUS INFECTIONR21AI116022 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FERNANDEZ-SESMA, ANA · 2015 to 2016
$461k
Cancer Research UKMedical Research CouncilNIAID NIH HHS R01 AI064001NIAID NIH HHS R01 AI073450NIAID NIH HHS R01 AI120998NIAID NIH HHS R21 AI116022NIAID NIH HHS U19 AI118610NIGMS NIH HHS R01 GM113886Wellcome Trust
6 · The paper itself

Abstract

Endogenous retroviruses (ERVs) occupy extensive regions of the human genome. Although many of these retroviral elements have lost their ability to replicate, those whose insertion took place more recently, such as the HML-2 group of HERV-K elements, still retain intact open reading frames and the capacity to produce certain viral RNA and/or proteins. Transcription of these ERVs is, however, tightly regulated by dedicated epigenetic control mechanisms. Nonetheless, it has been reported that some pathological states, such as viral infections and certain cancers, coincide with ERV expression, suggesting that transcriptional reawakening is possible. HML-2 elements are reportedly induced during HIV-1 infection, but the conserved nature of these elements has, until recently, rendered their expression profiling problematic. Here, we provide comprehensive HERV-K HML-2 expression profiles specific for productively HIV-1-infected primary human CD4

Indexed as

Gene Expression Regulation, ViralCD4-Positive T-LymphocytesCells, CulturedEndogenous RetrovirusesGenome, HumanHIV-1HumansProvirusesRNA, ViralViral Envelope ProteinsViral ProteinsRNA, ViralViral Envelope ProteinsViral ProteinsCD4+ T cellsHERV-KHIV-1

Identifiers

PMID29046457
PMCPMC5730760
OpenAlexW2803575942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.